Osteoporosis affects about 200 million people worldwide and is a silent disease until a
fracture occurs. Management of osteoporosis is still a challenge that warrants further studies …

Osteoporosis is a common disease that affects millions of patients worldwide and is most
common in menopausal women. The main characteristics of osteoporosis are low bone …

Osteoporosis is a bone disease characterized by increasing osseous fragility and fracture
due to the reduced bone mass and microstructural degradation. Primary pharmacological …

Osteoporosis, a systemic skeletal disease characterized by a decrease in bone mass and
deterioration of bone structure leading to an increased risk of fragility fractures, represents …

Osteoporosis bone defect is a refractory orthopaedic disease which characterized by
impaired bone quality and bone regeneration capacity. Current therapies, including …

The aim of this work was to prepare a biocompatible implant material that enables the
release of drug for osteoporosis—risedronate. To achieve this goal, a titanium implant …

Bone vasculature influences osteogenesis and haematopoiesis in the bone
microenviroment. Mechanical loading has been shown to stimulate the formation of …

Osteoporosis is a bone disorder characterised by low bone mineral density, reduced bone
strength, increased bone fragility, and impaired mineralisation of bones causing an …

The prevalence of osteoporosis among women aged 50 y and older is expected to reach
13.6 million by 2030. Alternative nonpharmaceutical agents for osteoporosis, including …

Osteoclasts derived from the monocyte/macrophage hematopoietic lineage regulate bone
resorption, a process balanced by bone formation in the continual renewal of the skeletal …